Business
Why the Alterity (ASX:ATH) share price is skyrocketing 42% today
One of the best performers on the ASX today is the Alterity Therapeutics Ltd (ASX: ATH) share price. Driving the meteoric rise, the biotech company announced positive results for its lead compound, ATH434.
At the time of writing, Alterity shares are swapping hands for 4.25 cents apiece, up 41.67%.
What does Alterity do?
Alterity is an Australian biotech company focused on commercialising research into neurodegenerative disorders. These include Parkinsonian movement disorders, Alzheimer’s disease, Huntington disease and others.
The company’s lead candidate ATH434 is currently in development. It aims to block the aggregation of pathological proteins that cause brain degeneration. Current remedies include medications and lifestyle…
-
Noosa News15 hours agoConsolidated Pastoral Company buys Beetaloo aggregation in historic deal worth more than $300m
-
General23 hours agoWotjobaluk Nations Festival marks landmark native title recognition
-
Noosa News20 hours agoEight New Year’s Eve Events in Brisbane 2026
-
General17 hours agoAustralian luger Alex Ferlazzo makes stunning recovery during run after falling off his sled